Total Payments
$14,933
2024 Payments
$1,643
Companies
65
Transactions
841
Medicare Patients
4,849
Medicare Billing
$301,947
Payment Breakdown by Category
Food & Beverage$14,694 (98.4%)
Education$239.12 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,694 | 832 | 98.4% |
| Education | $239.12 | 9 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,471 | 142 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,626 | 96 | $0 (2024) |
| PFIZER INC. | $1,252 | 85 | $0 (2024) |
| ABBVIE INC. | $1,209 | 74 | $0 (2024) |
| Lilly USA, LLC | $1,071 | 56 | $0 (2024) |
| Amgen Inc. | $772.03 | 35 | $0 (2024) |
| GlaxoSmithKline, LLC. | $738.82 | 47 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $621.34 | 33 | $0 (2023) |
| Astellas Pharma US Inc | $384.25 | 16 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $343.61 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,643 | 88 | ABBVIE INC. ($393.70) |
| 2023 | $1,696 | 97 | Novo Nordisk Inc ($337.18) |
| 2022 | $1,735 | 103 | Novo Nordisk Inc ($334.40) |
| 2021 | $2,123 | 133 | Novo Nordisk Inc ($390.46) |
| 2020 | $1,914 | 123 | AstraZeneca Pharmaceuticals LP ($301.45) |
| 2019 | $1,799 | 98 | Novo Nordisk Inc ($358.29) |
| 2018 | $1,577 | 93 | Amgen Inc. ($276.39) |
| 2017 | $2,444 | 106 | AstraZeneca Pharmaceuticals LP ($481.63) |
All Payment Transactions
841 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Obesity | ||||||
| 11/26/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: UROLOGY | ||||||
| 09/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Obesity | ||||||
| 09/25/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Obesity | ||||||
| 08/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 882 | 1,121 | $211,110 | $77,730 |
| 2022 | 14 | 918 | 1,218 | $194,217 | $71,139 |
| 2021 | 12 | 1,115 | 1,504 | $196,084 | $72,342 |
| 2020 | 28 | 1,934 | 2,590 | $251,881 | $80,736 |
Total Patients
4,849
Total Services
6,433
Medicare Billing
$301,947
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 236 | 383 | $78,515 | $28,928 | 36.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 186 | 186 | $60,264 | $22,419 | 37.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 130 | 155 | $21,545 | $9,018 | 41.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $9,493 | $3,097 | 32.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 49 | $6,811 | $2,836 | 41.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 30 | 30 | $5,490 | $2,274 | 41.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 131 | 131 | $6,943 | $2,209 | 31.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 21 | $4,200 | $1,904 | 45.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $5,340 | $1,844 | 34.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $5,706 | $1,436 | 25.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 30 | 30 | $2,100 | $866.10 | 41.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $1,050 | $433.05 | 41.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 47 | $3,290 | $354.26 | 10.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 29 | 33 | $363.00 | $112.53 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 250 | 429 | $87,945 | $32,725 | 37.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 176 | 176 | $57,024 | $21,630 | 37.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 107 | $14,873 | $6,156 | 41.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 126 | 126 | $6,678 | $2,137 | 32.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 25 | $5,000 | $1,949 | 39.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 27 | 27 | $4,941 | $1,897 | 38.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 25 | $3,475 | $1,242 | 35.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $6,023 | $1,168 | 19.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 27 | 27 | $1,890 | $733.59 | 38.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 23 | 23 | $1,610 | $629.83 | 39.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 44 | $3,080 | $375.84 | 12.2% |
About Dr. Thomas Garner, M.D
Dr. Thomas Garner, M.D is a Internal Medicine healthcare provider based in Richmond Hill, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2011. The National Provider Identifier (NPI) number assigned to this provider is 1801185442.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Garner, M.D has received a total of $14,933 in payments from pharmaceutical and medical device companies, with $1,643 received in 2024. These payments were reported across 841 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($14,694).
As a Medicare-enrolled provider, Garner has provided services to 4,849 Medicare beneficiaries, totaling 6,433 services with total Medicare billing of $301,947. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Richmond Hill, GA
- Active Since 04/05/2011
- Last Updated 01/27/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1801185442
Products in Payments
- FARXIGA (Drug) $1,409
- VRAYLAR (Drug) $747.78
- Ozempic (Drug) $642.23
- Saxenda (Drug) $502.39
- Wegovy (Drug) $442.01
- ELIQUIS (Drug) $433.03
- JARDIANCE (Drug) $414.81
- CHANTIX (Drug) $358.02
- UBRELVY (Drug) $353.16
- TRULICITY (Drug) $346.49
- TRELEGY ELLIPTA (Drug) $346.33
- MOUNJARO (Drug) $308.46
- TOUJEO (Drug) $306.69
- NURTEC ODT (Drug) $305.06
- Rybelsus (Drug) $301.23
- Livalo (Drug) $282.02
- Aimovig (Biological) $271.40
- SOLIQUA 100/33 (Biological) $260.49
- Otezla (Drug) $260.39
- XARELTO (Drug) $251.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Richmond Hill
Dr. Douglas Perry, M.d, M.D
Internal Medicine — Payments: $10,239
Internal Medicine $10,239
Mrs. Rana Suleman, M.d, M.D
Internal Medicine — Payments: $7,998
Internal Medicine $7,998
Dr. Edward Hoffman, M.d, M.D
Internal Medicine — Payments: $6,744
Internal Medicine $6,744
Rita Jhaveri, Md, MD
Internal Medicine — Payments: $6,453
Internal Medicine $6,453
Dr. Wallace Holland, M.d, M.D
Internal Medicine — Payments: $3,068
Internal Medicine $3,068
Donald Cobb, Md, MD
Internal Medicine — Payments: $2,737
Internal Medicine $2,737